- Home
- TCBS vs QNCX Comparison
TCBS vs QNCX Comparison
Compare TCBS & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBS
- QNCX
- Stock Information
- Founded
- TCBS 1934
- QNCX 2012
- Country
- TCBS United States
- QNCX United States
- Employees
- TCBS N/A
- QNCX N/A
- Industry
- TCBS Banks
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TCBS Finance
- QNCX Health Care
- Exchange
- TCBS Nasdaq
- QNCX Nasdaq
- Market Cap
- TCBS 44.9M
- QNCX 44.0M
- IPO Year
- TCBS N/A
- QNCX 2019
- Fundamental
- Price
- TCBS $15.81
- QNCX $0.95
- Analyst Decision
- TCBS
- QNCX Strong Buy
- Analyst Count
- TCBS 0
- QNCX 5
- Target Price
- TCBS N/A
- QNCX $8.00
- AVG Volume (30 Days)
- TCBS 1.3K
- QNCX 536.2K
- Earning Date
- TCBS 05-20-2025
- QNCX 05-13-2025
- Dividend Yield
- TCBS 1.01%
- QNCX N/A
- EPS Growth
- TCBS N/A
- QNCX N/A
- EPS
- TCBS 0.68
- QNCX N/A
- Revenue
- TCBS $14,488,000.00
- QNCX N/A
- Revenue This Year
- TCBS N/A
- QNCX N/A
- Revenue Next Year
- TCBS N/A
- QNCX N/A
- P/E Ratio
- TCBS $23.34
- QNCX N/A
- Revenue Growth
- TCBS 54.08
- QNCX N/A
- 52 Week Low
- TCBS $13.51
- QNCX $0.51
- 52 Week High
- TCBS $17.50
- QNCX $2.45
- Technical
- Relative Strength Index (RSI)
- TCBS 55.07
- QNCX 32.57
- Support Level
- TCBS $15.25
- QNCX $0.98
- Resistance Level
- TCBS $15.63
- QNCX $1.06
- Average True Range (ATR)
- TCBS 0.05
- QNCX 0.09
- MACD
- TCBS 0.05
- QNCX -0.00
- Stochastic Oscillator
- TCBS 90.51
- QNCX 7.08
About TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.